Abstract
Diffuse alveolar hemorrhage (DAH) is a recognized pulmonary complication in the setting of hematopoietic STC (HSCT). DAH after HSCT is often fatal, but the exact etiology remains unclear. DAH after HSCT is reported in 1–5% of autologous graft recipients and in 3–7% of allogeneic graft recipients.1, 2, 3, 4 Umbilical cord blood transplantation (CBT) from unrelated donors has recently increased in popularity for adult patients with hematological diseases who have no other suitable donor. However, DAH in the setting of post CBT has not been discussed in detail.4 We describe herein, a case of a patient with DAH after CBT who was successfully treated with relatively low-dose steroid therapy using prednisolone at 1 mg/kg/day.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call